Vertex Pharmaceuticals (VRTX) | Chart & Forecast SummaryRight Here You Can See Vertex Pharmaceuticals Incorporated (VRTX) Registered As (VRTX) On The New York Stock Exchange, Vertex Pharmaceuticals Incorporated Is An American Biopharmaceutical Company Based In Boston, Massachusetts.
The Following Chart & Forecast Summary On Vertex Pharmaceuticals Incorp
Key facts today
VRTX Bull FlagVRTX is approaching the top end of bull flag on the 4hr. A break could lead to a move back up to ATH and beyond. The flag pole on this one is pretty big so if going on that projection it could see $600 if it does get continuation above.
A bearish scenario would be a rejection here at the top end or
Buy Vertex PharmaceuticalsShort Term Trading Advice by Naranj Capital
Buy Vertex Pharmaceuticals
● Buy Range- 475 - 480
● Target- 500 - 505
● StopLoss- 460
● Potential Return- 5-6%
● Duration- 12-14 Trading Days
VRTX upside?Beautiful bullflag breaking on the hourly and higher time frames, Targeting previous highs
Eyes on VRTXVRTX bouncing nicely off recent lows and has broken downtrend. Final confirmation would be a daily close over 421.50. Looking to enter a starter position and will add on a retest of the daily 48.
Vertex Pharmaceuticals pioneers with non-opioid painkiller VX-54Vertex Pharmaceuticals Inc., widely recognised for its cystic fibrosis treatments, is venturing into new therapeutic areas , signalling potential growth in new markets. The company is currently advancing its development of non-opioid analgesics, specifically candidate VX-548, which has demonstrated
In waiting for a retestAre you interrested in buying NASDAQ:VRTX ? I'm looking for a break confirmation of the 2-years trendline to evaluate a first entry in the 370s. Then the POC line could be a valid support to regain the trend.
VRTX Stock – the Alternative to OxyContin?In the wake of the opiod epidemic, brought on in part by the success of Oxycodone, a new exceptional drug is being developed by Vertex Pharmaceuticals (NASDAQ: VRTX). With the intention of providing relief from severe pain without the addictive properties of opioids, Vertex’s new drug could be on tr
temporary pain for long term gainsAs price action is currently receiving short term bearishness from sellers from being near all time highs, accumulation of shares are lessening however the uptrend has been strong overall. Look for more of a pullback leading into earnings and with strong support should provide another entry long in
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where VRTX is featured.
